Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cyclosporin A binding	PPIAL4C PPIAL4E PPIAL4D PPIAL4F	1.10e-06	24	66	4	GO:0016018
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	PPIAL4C PPIAL4E PPIAL4D PPIAL4F	2.24e-05	50	66	4	GO:0003755
GeneOntologyMolecularFunction	cis-trans isomerase activity	PPIAL4C PPIAL4E PPIAL4D PPIAL4F	2.82e-05	53	66	4	GO:0016859
GeneOntologyMolecularFunction	extracellular matrix structural constituent	COL4A4 THBS4 FBN2 COL15A1 MUC2	3.94e-04	188	66	5	GO:0005201
GeneOntologyBiologicalProcess	protein peptidyl-prolyl isomerization	PPIAL4C PPIAL4E PPIAL4D PPIAL4F	6.12e-06	38	65	4	GO:0000413
GeneOntologyBiologicalProcess	peptidyl-proline modification	PPIAL4C PPIAL4E PPIAL4D PPIAL4F	2.52e-05	54	65	4	GO:0018208
HumanPheno	Brain atrophy	PDPN DPYD ERCC5 MAN2B1 KIF26A PCLO CIZ1 CACNA1I GTF2IRD1 TSEN15 DNMT1 RUSC2	1.59e-05	802	21	12	HP:0012444
HumanPheno	Brain very small	PDPN DPYD ERCC5 MAN2B1 KIF26A PCLO CIZ1 CACNA1I GTF2IRD1 TSEN15 DNMT1 RUSC2	1.59e-05	802	21	12	HP:0001322
HumanPheno	Cerebral hypoplasia	PDPN DPYD ERCC5 MAN2B1 KIF26A PCLO CIZ1 CACNA1I GTF2IRD1 TSEN15 DNMT1 RUSC2	2.71e-05	844	21	12	HP:0006872
Domain	Cyclophilin-type_PPIase_CS	PPIAL4C PPIAL4D PPIAL4F	3.75e-05	19	65	3	IPR020892
Domain	Cyclophilin-type_PPIase	PPIAL4C PPIAL4D PPIAL4F	5.12e-05	21	65	3	IPR024936
Domain	Cyclophilin-like_dom	PPIAL4C PPIAL4D PPIAL4F	5.91e-05	22	65	3	IPR029000
Domain	CSA_PPIASE_2	PPIAL4C PPIAL4D PPIAL4F	5.91e-05	22	65	3	PS50072
Domain	Pro_isomerase	PPIAL4C PPIAL4D PPIAL4F	5.91e-05	22	65	3	PF00160
Domain	-	PPIAL4C PPIAL4D PPIAL4F	5.91e-05	22	65	3	2.40.100.10
Domain	Cyclophilin-type_PPIase_dom	PPIAL4C PPIAL4D PPIAL4F	5.91e-05	22	65	3	IPR002130
Domain	CSA_PPIASE_1	PPIAL4C PPIAL4D PPIAL4F	5.91e-05	22	65	3	PS00170
Domain	EGF_3	THBS4 NRXN3 FBN2 UMODL1 ADAM30 PLAT	1.65e-04	235	65	6	PS50026
Domain	EGF-like_dom	THBS4 NRXN3 FBN2 UMODL1 ADAM30 PLAT	2.26e-04	249	65	6	IPR000742
Domain	EGF_1	THBS4 NRXN3 FBN2 UMODL1 ADAM30 PLAT	2.57e-04	255	65	6	PS00022
Domain	BROMODOMAIN_1	BAZ2B CECR2 SP140	2.87e-04	37	65	3	PS00633
Domain	EGF-like_CS	THBS4 NRXN3 FBN2 UMODL1 ADAM30 PLAT	2.91e-04	261	65	6	IPR013032
Domain	Bromodomain	BAZ2B CECR2 SP140	3.11e-04	38	65	3	PF00439
Domain	EGF_2	THBS4 NRXN3 FBN2 UMODL1 ADAM30 PLAT	3.16e-04	265	65	6	PS01186
Domain	BROMODOMAIN_2	BAZ2B CECR2 SP140	3.90e-04	41	65	3	PS50014
Domain	BROMO	BAZ2B CECR2 SP140	4.19e-04	42	65	3	SM00297
Domain	Bromodomain	BAZ2B CECR2 SP140	4.19e-04	42	65	3	IPR001487
Domain	-	BAZ2B CECR2 SP140	4.19e-04	42	65	3	1.20.920.10
Domain	Laminin_G	THBS4 NRXN3 COL15A1	1.08e-03	58	65	3	IPR001791
Domain	EGF	THBS4 NRXN3 FBN2 UMODL1 PLAT	1.35e-03	235	65	5	SM00181
Domain	Kringle	PLAT F2	1.57e-03	17	65	2	IPR000001
Domain	Kringle_CS	PLAT F2	1.57e-03	17	65	2	IPR018056
Domain	KRINGLE_2	PLAT F2	1.57e-03	17	65	2	PS50070
Domain	Kringle	PLAT F2	1.57e-03	17	65	2	PF00051
Domain	KRINGLE_1	PLAT F2	1.57e-03	17	65	2	PS00021
Domain	KR	PLAT F2	1.57e-03	17	65	2	SM00130
Domain	TSPN	THBS4 COL15A1	2.88e-03	23	65	2	SM00210
Domain	EGF_CA	THBS4 FBN2 UMODL1	3.35e-03	86	65	3	PF07645
Domain	Bromodomain_CS	BAZ2B CECR2	3.67e-03	26	65	2	IPR018359
Domain	Znf_PHD	ASXL1 BAZ2B SP140	3.93e-03	91	65	3	IPR001965
Domain	ZF_PHD_2	ASXL1 BAZ2B SP140	4.43e-03	95	65	3	PS50016
Domain	ZF_PHD_1	ASXL1 BAZ2B SP140	4.57e-03	96	65	3	PS01359
Domain	EGF_Ca-bd_CS	THBS4 FBN2 UMODL1	4.70e-03	97	65	3	IPR018097
Domain	EGF_CA	THBS4 FBN2 UMODL1	4.97e-03	99	65	3	PS01187
Domain	ASX_HYDROXYL	NRXN3 FBN2 UMODL1	5.12e-03	100	65	3	PS00010
Domain	Kringle-like	PLAT F2	5.53e-03	32	65	2	IPR013806
Domain	TRYPSIN_SER	OVCH2 PLAT F2	6.01e-03	106	65	3	PS00135
Domain	EGF-type_Asp/Asn_hydroxyl_site	NRXN3 FBN2 UMODL1	6.01e-03	106	65	3	IPR000152
Domain	TRYPSIN_HIS	OVCH2 PLAT F2	6.17e-03	107	65	3	PS00134
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A4 PLAT F2	1.08e-05	14	45	3	MM1458
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	COL4A4 PLAT F2	1.08e-05	14	45	3	M6487
Pathway	BIOCARTA_AMI_PATHWAY	COL4A4 PLAT F2	3.34e-05	20	45	3	M15394
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	COL4A4 ELOC ABL2 UPF2 TRIO CACNA1I PLXNB1 FARP2	4.14e-04	575	45	8	M29853
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL4A4 FBN2 COL15A1 MMP14	4.68e-04	114	45	4	MM14571
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL4A4 COL15A1 MMP14	6.37e-04	53	45	3	MM14566
Pathway	BIOCARTA_FIBRINOLYSIS_PATHWAY	PLAT F2	6.44e-04	12	45	2	M2842
Pathway	BIOCARTA_FIBRINOLYSIS_PATHWAY	PLAT F2	6.44e-04	12	45	2	MM1398
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A4 THBS4 PLAT	7.88e-04	57	45	3	MM14713
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A4 THBS4 PLAT	8.30e-04	58	45	3	M2049
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FLT3	SOCS2 ABL2	8.85e-04	14	45	2	MM15682
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	COL4A4 FBN2 COL15A1 MMP14	1.01e-03	140	45	4	M587
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FLT3	SOCS2 ABL2	1.02e-03	15	45	2	M41735
Pathway	REACTOME_COLLAGEN_DEGRADATION	COL4A4 COL15A1 MMP14	1.11e-03	64	45	3	M26953
Pubmed	Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease.	PDPN ABCA3 FBN2 MMP14	3.18e-06	52	67	4	30389913
Pubmed	Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors.	DPYD PER1	3.66e-06	2	67	2	17699798
Pubmed	An unusual C(2)-domain in the active-zone protein piccolo: implications for Ca(2+) regulation of neurotransmitter release.	PCLO PER1	3.66e-06	2	67	2	11285225
Pubmed	Serendipitous SAD Solution for DMSO-Soaked SOCS2-ElonginC-ElonginB Crystals Using Covalently Incorporated Dimethylarsenic: Insights into Substrate Receptor Conformational Flexibility in Cullin RING Ligases.	SOCS2 ELOC	1.10e-05	3	67	2	26121586
Pubmed	The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.	PLAT F2	1.10e-05	3	67	2	10543954
Pubmed	NOX5 variants are functionally active in endothelial cells.	NOX5 F2	1.10e-05	3	67	2	17275676
Pubmed	Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: implications for airway smooth muscle migration.	F2 MMP14	1.10e-05	3	67	2	17189319
Pubmed	Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2.	SOCS2 ELOC	1.10e-05	3	67	2	37816714
Pubmed	Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands.	SOCS2 ELOC	1.10e-05	3	67	2	34857742
Pubmed	Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes.	SOCS2 ELOC	2.19e-05	4	67	2	23897481
Pubmed	SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.	SOCS2 ELOC	2.19e-05	4	67	2	35995846
Pubmed	A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).	COL4A4 THBS4 PLAT F2 MMP14	3.06e-05	186	67	5	20673868
Pubmed	Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.	COL4A4 THBS4 PLAT F2 MMP14	3.06e-05	186	67	5	20452482
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MAN2B1 UPF2 WDR6 SENP3 PLXNB1 DNMT1 RUSC2 FARP2	3.52e-05	650	67	8	38777146
Pubmed	Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex.	SOCS2 ELOC	3.64e-05	5	67	2	23098073
Pubmed	The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.	SOCS2 ELOC	3.64e-05	5	67	2	16643902
Pubmed	Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.	PLAT F2	3.64e-05	5	67	2	1695900
Pubmed	Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.	SOCS2 ELOC	3.64e-05	5	67	2	16675548
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 ABL2 TRIO WDR6 TNKS1BP1 DNMT1	4.42e-05	332	67	6	37433992
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NHSL1 MAN2B1 TRIO KIF26A KCNG1 KHNYN PER1 TNKS1BP1 GTF2IRD1 MMP14	4.83e-05	1105	67	10	35748872
Pubmed	Asxl1 exerts an antiproliferative effect on mouse lung maturation via epigenetic repression of the E2f1-Nmyc axis.	PDPN ASXL1 ABCA3	5.07e-05	37	67	3	30389914
Pubmed	[Pharmacogenetics of the local thrombolysis in patients with deep vein thrombosis].	PLAT F2	5.46e-05	6	67	2	16466010
Pubmed	A complex interaction pattern of CIS and SOCS2 with the leptin receptor.	SOCS2 ELOC	5.46e-05	6	67	2	16684815
Pubmed	The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.	SOCS2 ELOC	5.46e-05	6	67	2	21980433
Pubmed	Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women.	PLAT F2	7.63e-05	7	67	2	12468767
Pubmed	The C-terminus of CIS defines its interaction pattern.	SOCS2 ELOC	7.63e-05	7	67	2	16961462
Pubmed	Extensive gene order differences within regions of conserved synteny between the Fugu and human genomes: implications for chromosomal evolution and the cloning of disease genes.	CIZ1 BBLN	7.63e-05	7	67	2	10369878
Pubmed	Fibrinogen Aalpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension.	PLAT F2	7.63e-05	7	67	2	18057060
Pubmed	Platelet GPIaC807T polymorphism is associated with negative outcome of sudden hearing loss.	PLAT F2	7.63e-05	7	67	2	15109703
Pubmed	Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.	SP140 FARP2	7.63e-05	7	67	2	22700719
Pubmed	NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium.	OVCH2 NRXN3	1.02e-04	8	67	2	19557197
Pubmed	Additional sex combs-like family genes are required for normal cardiovascular development.	PDPN ASXL1	1.30e-04	9	67	2	24860998
Pubmed	Elongin B/C recruitment regulates substrate binding by CIS.	SOCS2 ELOC	1.30e-04	9	67	2	18508766
Pubmed	Orphan G-Protein Coupled Receptor GPRC5B Is Critical for Lymphatic Development.	PDPN RAMP3	1.63e-04	10	67	2	35628521
Pubmed	The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.	SOCS2 ELOC	1.99e-04	11	67	2	19385048
Pubmed	Matrilin-2 interacts with itself and with other extracellular matrix proteins.	COL4A4 FBN2	2.38e-04	12	67	2	12180907
Pubmed	Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).	SOCS2 ELOC	2.38e-04	12	67	2	25505247
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NHSL1 ABL2 TRIO STARD9 TNKS1BP1 NCKAP5L DNMT1 RUSC2	2.45e-04	861	67	8	36931259
Pubmed	Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.	PLAT F2	2.81e-04	13	67	2	17003923
Pubmed	Genome-wide analysis of hepatic lipid content in extreme obesity.	SOCS2 RAMP3	2.81e-04	13	67	2	25246029
Pubmed	EMC3 coordinates surfactant protein and lipid homeostasis required for respiration.	PDPN ABCA3	2.81e-04	13	67	2	29083321
Pubmed	FOXD1 is required for 3D patterning of the kidney interstitial matrix.	COL4A4 FBN2	2.81e-04	13	67	2	36335435
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ELOC CECR2 SENP3 TNKS1BP1 ZNF831 DNMT1	2.90e-04	469	67	6	27634302
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL4A4 THBS4 COL15A1 MUC2	3.11e-04	167	67	4	22159717
Pubmed	A potential role of p75NTR in the regulation of circadian rhythm and incremental growth lines during tooth development.	PDLIM3 PER1	3.28e-04	14	67	2	36213234
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	ELOC ERCC5 KHNYN USP4 GTF2IRD1 DNMT1	3.32e-04	481	67	6	28190767
Pubmed	Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".	PDPN THBS4 PLAT MMP14	3.47e-04	172	67	4	20628624
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	COL4A4 FBN2 COL15A1 F2	3.71e-04	175	67	4	28071719
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BAZ2B CECR2 SP140	4.18e-04	75	67	3	25593309
Pubmed	Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.	PDLIM3 FHOD1	4.31e-04	16	67	2	16717059
Pubmed	Alterations in gene expression in T1 alpha null lung: a model of deficient alveolar sac development.	PDPN ASXL1	4.88e-04	17	67	2	16869965
Pubmed	Yap and its subcellular localization have distinct compartment-specific roles in the developing lung.	PDPN ABCA3	5.48e-04	18	67	2	30944105
Pubmed	β1-Integrin Deletion From the Lens Activates Cellular Stress Responses Leading to Apoptosis and Fibrosis.	PLAT MMP14	5.48e-04	18	67	2	28763805
Pubmed	Epithelial Notch signaling regulates lung alveolar morphogenesis and airway epithelial integrity.	PDPN ABCA3	5.48e-04	18	67	2	27364009
Pubmed	Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.	COL4A4 DNMT1	5.48e-04	18	67	2	9160753
Pubmed	A protein interaction framework for human mRNA degradation.	UPF2 FHOD1 CIZ1 GTF2IRD1 TSEN15	5.59e-04	347	67	5	15231747
Pubmed	Alveolar progenitor and stem cells in lung development, renewal and cancer.	PDPN ABCA3	6.12e-04	19	67	2	24499815
Pubmed	Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium.	MUC2 DNMT1	6.79e-04	20	67	2	26023099
Pubmed	PRMT7 targets of Foxm1 controls alveolar myofibroblast proliferation and differentiation during alveologenesis.	PDPN ABCA3	6.79e-04	20	67	2	34497269
Pubmed	Neonatal Respiratory Failure with Retarded Perinatal Lung Maturation in Mice Caused by Reticulocalbin 3 Disruption.	PDPN ABCA3	6.79e-04	20	67	2	26252542
Pubmed	Candidate genes and cerebral palsy: a population-based study.	PLAT F2	7.50e-04	21	67	2	18977990
Pubmed	Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.	PLAT F2	7.50e-04	21	67	2	19592578
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	NHSL1 PCLO SENP3 NCKAP5L	8.45e-04	218	67	4	33378226
Pubmed	Hypoxia inducible factor 3α plays a critical role in alveolarization and distal epithelial cell differentiation during mouse lung development.	PDPN ABCA3	9.01e-04	23	67	2	23451260
Pubmed	mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.	FHOD1 NCKAP5L TSEN15	9.12e-04	98	67	3	34943047
Pubmed	Lymphatic function is required prenatally for lung inflation at birth.	PDPN ABCA3	9.82e-04	24	67	2	24733830
Pubmed	Loss of semaphorin-neuropilin-1 signaling causes dysmorphic vascularization reminiscent of alveolar capillary dysplasia.	PDPN ABCA3	9.82e-04	24	67	2	23063659
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	CECR2 PCLO CIZ1 NCKAP5L DNMT1	1.03e-03	398	67	5	35016035
Pubmed	Single cell RNA analysis identifies cellular heterogeneity and adaptive responses of the lung at birth.	PDPN ABCA3	1.07e-03	25	67	2	30604742
Pubmed	PIDD orchestrates translesion DNA synthesis in response to UV irradiation.	ERCC5 SENP3	1.07e-03	25	67	2	21415862
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	WDR6 KHNYN USP4 GTF2IRD1 DNMT1 FARP2	1.09e-03	604	67	6	38803224
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	BAZ2B ACTBL2 USP4 CPNE7	1.12e-03	235	67	4	30258100
Pubmed	Lack of whey acidic protein (WAP) four-disulfide core domain protease inhibitor 2 (WFDC2) causes neonatal death from respiratory failure in mice.	PDPN ABCA3	1.15e-03	26	67	2	31562139
Pubmed	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	SP140 FARP2	1.15e-03	26	67	2	23770605
Pubmed	Array MAPPIT: high-throughput interactome analysis in mammalian cells.	SOCS2 ELOC	1.15e-03	26	67	2	19159283
Pubmed	siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.	FANCB ERCC5	1.15e-03	26	67	2	23435420
Pubmed	Analysis of a lung defect in autophagy-deficient mouse strains.	PDPN ABCA3	1.15e-03	26	67	2	24275123
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	NHSL1 ABL2 TRIO WDR6 FARP2	1.32e-03	421	67	5	36976175
Pubmed	A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.	PDPN ABCA3	1.34e-03	28	67	2	25912685
Pubmed	Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).	FBN2 PLAT F2 MMP14	1.34e-03	247	67	4	39238192
Pubmed	Kub3 Deficiency Causes Aberrant Late Embryonic Lung Development in Mice by the FGF Signaling Pathway.	PDPN ABCA3	1.54e-03	30	67	2	35682694
Pubmed	WNT5a-ROR Signaling Is Essential for Alveologenesis.	PDPN ABCA3	1.64e-03	31	67	2	32046118
Pubmed	Maternal synchronization of gestational length and lung maturation.	PDPN ABCA3	1.64e-03	31	67	2	22096492
Pubmed	The NANCI-Nkx2.1 gene duplex buffers Nkx2.1 expression to maintain lung development and homeostasis.	PDPN ABCA3	1.75e-03	32	67	2	28546511
Cytoband	1q21.2	PPIAL4C PPIAL4E PPIAL4D PPIAL4F	3.74e-06	71	67	4	1q21.2
Cytoband	9q34.1	CIZ1 BBLN	3.53e-04	19	67	2	9q34.1
GeneFamily	Collagens	COL4A4 COL15A1	3.57e-03	46	35	2	490
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF26A STARD9	3.57e-03	46	35	2	622
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO FARP2	7.23e-03	66	35	2	722
GeneFamily	PHD finger proteins	BAZ2B SP140	1.31e-02	90	35	2	88
GeneFamily	SH2 domain containing	SOCS2 ABL2	1.63e-02	101	35	2	741
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP	PDPN DPYD FHOD1 PER1 MMP14 RUSC2	7.89e-06	200	62	6	M6655
CoexpressionAtlas	Endoderm Differentiated Cells_vs_Ectoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05	SOCS2 PDPN PPIAL4C PPIAL4E PPIAL4D KIF26A KCNG1 FHOD1 GMDS FAM124A MMP14 PPIAL4F	5.42e-06	796	66	12	PCBC_ratio_DE_vs_ECTO_cfr-2X-p05
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SOCS2 NRXN3 FBN2 PDLIM3 PLAT MMP14	3.61e-07	185	67	6	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ASXL1 COL15A1 TRIO MMP14 NCKAP5L RUSC2	3.97e-07	188	67	6	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	Fibroblast-B_(Myofibroblast)\|World / shred on cell class and cell subclass (v4)	SOCS2 NRXN3 COL15A1 PDLIM3 PLAT MMP14	4.92e-07	195	67	6	a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 NRXN3 COL15A1 PDLIM3 PLAT CPNE7	5.06e-07	196	67	6	9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 NRXN3 COL15A1 PDLIM3 PLAT CPNE7	5.22e-07	197	67	6	7d97c2d51a543c02d679e9257b22d0581e73a11d
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 NRXN3 COL15A1 PDLIM3 PLAT CPNE7	5.22e-07	197	67	6	671d6b5effbac2dd71d18f48d23c523738db1828
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 NRXN3 COL15A1 PDLIM3 PLAT MMP14	5.22e-07	197	67	6	9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 NRXN3 COL15A1 PDLIM3 PLAT MMP14	5.22e-07	197	67	6	090a251194da3e2806989d9a522588f83f52da7f
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A4 PDPN NRXN3 FBN2 FHOD1 PLXNB1	5.37e-07	198	67	6	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A4 ABCA3 NRXN3 CECR2 FHOD1 PLXNB1	5.70e-07	200	67	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 PDPN COL15A1 ZBTB7C MMP14	6.87e-06	176	67	5	fee4e0f32aaf77294040c7af6c1f503571750d43
ToppCell	facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 PDPN COL15A1 ZBTB7C MMP14	6.87e-06	176	67	5	f25251abd4ef9fb077a978f9f9f658af58e4e0d2
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 PDPN NRXN3 CECR2 FHOD1	7.06e-06	177	67	5	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SOCS2 FBN2 CEBPE CECR2 PLAT	7.45e-06	179	67	5	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2 TNKS1BP1	8.52e-06	184	67	5	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN NHSL1 FBN2 PLAT MMP14	8.75e-06	185	67	5	01bbe1e09f9ccae837a03ea2cdd168fa10800942
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2 TNKS1BP1	9.21e-06	187	67	5	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN NHSL1 FBN2 PLAT MMP14	9.45e-06	188	67	5	e54e09d34e263d5709c337914809e61e74e20591
ToppCell	droplet-Fat-Scat-21m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN NHSL1 FBN2 PLAT MMP14	9.45e-06	188	67	5	7fc9810ab14354cb512e2b1285562009c10203f5
ToppCell	P07\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SOCS2 RAMP3 PDLIM3 PLAT MMP14	9.95e-06	190	67	5	38a613a9bca0ba040c3ada00286d1ce6f83ab23a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NRXN3 COL15A1 ZBTB7C PDLIM3 STARD9	1.02e-05	191	67	5	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PDPN THBS4 RAMP3 ZBTB7C MMP14	1.10e-05	194	67	5	69362e13158033de44f90f3773db6c0f27de8cb3
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.13e-05	195	67	5	2514c1f23424b5fc664d326d31ffd22bafe74ef8
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.16e-05	196	67	5	e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.16e-05	196	67	5	f0fd7db22985d2bc84dc8bcbdb2d552e280121dd
ToppCell	MatrixFB-Fibroblast-B_(Myofibroblast)\|MatrixFB / shred on cell class and cell subclass (v4)	NRXN3 COL15A1 PDLIM3 PLAT MMP14	1.16e-05	196	67	5	38ea0eaf42f95c321ca23570d0d7752980cf00f8
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.19e-05	197	67	5	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A4 ABCA3 NRXN3 FHOD1 PLXNB1	1.19e-05	197	67	5	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SOCS2 NRXN3 PDLIM3 PLAT MMP14	1.19e-05	197	67	5	2cec938caf6ffd031cea37277071487e59b2c71c
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SOCS2 NRXN3 PDLIM3 PLAT MMP14	1.19e-05	197	67	5	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NRXN3 COL15A1 PDLIM3 PLAT MMP14	1.19e-05	197	67	5	43b5f8e917506c1717f9311584901b506ffd2c79
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.19e-05	197	67	5	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.21e-05	198	67	5	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL4A4 NRXN3 KCNG1 FHOD1 PLXNB1	1.21e-05	198	67	5	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.21e-05	198	67	5	0993d6895c0e4f360998ce35abea4ec3dd13e048
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 FBN2 PDLIM3 PLAT MMP14	1.21e-05	198	67	5	a699b365d3b6149f13f02b2e2ae9b6fdce761848
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SOCS2 COL15A1 RAMP3 FAM124A PLAT	1.24e-05	199	67	5	d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL4A4 NRXN3 KCNG1 FHOD1 PLXNB1	1.24e-05	199	67	5	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL4A4 ABCA3 NRXN3 KCNG1 PLXNB1	1.24e-05	199	67	5	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A4 ABCA3 NRXN3 FHOD1 PLXNB1	1.27e-05	200	67	5	9a6ae40f3e17cd44ee5fd73260713b920aa2ea15
ToppCell	Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 NRXN3 COL15A1 KHNYN	2.84e-05	116	67	4	b0a3c109c5f20ab699e53bf8ab3903d102f5f315
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	KCNG1 CACNA1I ZNF831 CPNE7	7.14e-05	147	67	4	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDPN COL15A1 ABL2 MMP14	9.68e-05	159	67	4	34c90711c5857cf6ada7b3acff99f1d48c7caf29
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOCS2 THBS4 PDLIM3 PLAT	1.04e-04	162	67	4	3f264263878af630921911c2b344ac56eb1e7099
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAMP3 ZBTB7C CACNA1I PLAT	1.12e-04	165	67	4	6a621b300442c52adfc15b61d3a6d3a3cb00099f
ToppCell	CV-Mild-6\|CV / Virus stimulation, Condition and Cluster	MAN2B1 STARD9 SENP3 USP4	1.17e-04	167	67	4	cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf
ToppCell	10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-ELP\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SOCS2 OVCH2 UMODL1 ZNF831	1.25e-04	170	67	4	a50e558d0b38100ccbdccb90647fe93e85bffd86
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 COL15A1 FAM124A CPNE7	1.40e-04	175	67	4	b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 COL15A1 FAM124A CPNE7	1.40e-04	175	67	4	ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCell	droplet-Fat-Bat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 COL15A1 FAM124A CPNE7	1.40e-04	175	67	4	7f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	PDPN NOX5 MMP14 PLXNB1	1.46e-04	177	67	4	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-basal_proximal\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PDPN OVCH2 NRXN3 MUC2	1.49e-04	178	67	4	9534c4f4e950bb1498c1737ca1713e7f37d0aff2
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A4 COL15A1 MMP14 CPNE7	1.56e-04	180	67	4	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	Endothelial-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	RAMP3 PDLIM3 STARD9 ZNF831	1.59e-04	181	67	4	4fe0215d08f03d4e24749d70fce01b7aa22906fd
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDLIM3 KIF26A PLAT FARP2	1.59e-04	181	67	4	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL15A1 RAMP3 PDLIM3 PLAT	1.66e-04	183	67	4	858682df5592c6856487487a7baabd6e60e63a38
ToppCell	3'-Adult-SmallIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL15A1 RAMP3 PDLIM3 PLAT	1.66e-04	183	67	4	f8212bf8a8b8312434ae030261c558c147f61747
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.66e-04	183	67	4	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL15A1 RAMP3 ZBTB7C PLAT	1.66e-04	183	67	4	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZBTB7C PDLIM3 CECR2 PLAT	1.66e-04	183	67	4	351d575339038bd4a66f408da518c567444208e8
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	COL4A4 PDPN OVCH2 PCLO	1.66e-04	183	67	4	6821dca076318115d360ff426eb1218cfe104063
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.70e-04	184	67	4	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.70e-04	184	67	4	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	COPD-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	SOCS2 COL15A1 RAMP3 PLAT	1.73e-04	185	67	4	4abe04198ab5047c211f8d09cdb9650fa52a3cd6
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.77e-04	186	67	4	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	COPD-Endothelial-VE_Peribronchial\|COPD / Disease state, Lineage and Cell class	SOCS2 COL15A1 RAMP3 PLAT	1.77e-04	186	67	4	23c7d0e8372a71546d687278b985f761d282f92f
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL4A4 PDPN THBS4 ZBTB7C	1.77e-04	186	67	4	1587667e5084ac43505d027af925ba711e228150
ToppCell	facs-Heart-LA-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN PDLIM3 MMP14 CPNE7	1.77e-04	186	67	4	ed0a91f47e77fe21d4c7678d0f2a7c5f97d63dda
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.81e-04	187	67	4	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN PDLIM3 MMP14 CPNE7	1.81e-04	187	67	4	f3ef3f5a761f8306edc39bf16e76e44aae6fa7f6
ToppCell	facs-Heart-LA-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN PDLIM3 MMP14 CPNE7	1.81e-04	187	67	4	1669df899b1759c338ffce196fe009840123cfcd
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 PCLO ZNF831 CPNE7	1.81e-04	187	67	4	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 PCLO ZNF831 CPNE7	1.81e-04	187	67	4	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRXN3 PCLO ZNF831 CPNE7	1.81e-04	187	67	4	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDPN NRXN3 PCLO MMP14	1.84e-04	188	67	4	dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.84e-04	188	67	4	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	SOCS2 ABCA3 NRXN3 PCLO	1.84e-04	188	67	4	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDPN NRXN3 PCLO MMP14	1.84e-04	188	67	4	2ef08313087e91985bcffc46c3798470cdeec49c
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDPN NRXN3 PCLO MMP14	1.84e-04	188	67	4	1f1604b6dc0a8ad0be3d9aac0bef448459c22465
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL4A4 PDPN THBS4 COL15A1	1.84e-04	188	67	4	bba6b273bd47dd0e27fde914e9e6fc9d76fd5176
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDPN THBS4 RAMP3 ZBTB7C	1.84e-04	188	67	4	0e2d1b21f0a7ee306e7dae16fc8c19d16a467883
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A4 ABCA3 NRXN3 CECR2	1.88e-04	189	67	4	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL15A1 RAMP3 ZBTB7C PDLIM3	1.88e-04	189	67	4	473b01c9162b12b90a617c600238436177a0d18d
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDPN THBS4 RAMP3 PDLIM3	1.88e-04	189	67	4	c392491aabe8a3e90974ab2ea123bbbe5200439d
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL15A1 PDLIM3 DACT3 FAM124A	1.88e-04	189	67	4	63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FANCB PDLIM3 KIF26A PLAT	1.88e-04	189	67	4	2e43428f1ef9683c6f8c9897d46aa7d34bf9047f
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN COL15A1 PLAT MMP14	1.92e-04	190	67	4	bd0d68dc1b6f388190a6ba8a83b011619abe2bdd
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN COL15A1 PLAT MMP14	1.92e-04	190	67	4	e275de94468872e70cf305b3b450823d4c9c5e3f
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NHSL1 ZBTB7C PDLIM3 PLAT	1.92e-04	190	67	4	3b9abc25b17e7295356ded57ff2ca519fa9f2686
ToppCell	droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN COL15A1 PLAT MMP14	1.92e-04	190	67	4	ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70
ToppCell	facs-GAT-Fat-24m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN FAM124A PLAT MMP14	1.92e-04	190	67	4	3720e64129f3f3268b1dc14031a76f41c38241c2
ToppCell	facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN FAM124A PLAT MMP14	1.92e-04	190	67	4	73a50426f972f08f9bb525ad5c0b774187ab5d6a
ToppCell	COVID-19-Heart-EC_3\|Heart / Disease (COVID-19 only), tissue and cell type	RAMP3 ZBTB7C GMDS PLAT	1.92e-04	190	67	4	78e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCell	facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDPN FAM124A PLAT MMP14	1.92e-04	190	67	4	b55cf1fb586b724295b7b038483249847bb344fc
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ELOC COL15A1 RAMP3 PLAT	1.92e-04	190	67	4	a318d80dd5cc33d43048883b0e7844b5aa280aab
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A4 UPF2 TRIO SP140	1.92e-04	190	67	4	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDPN ELOC PDLIM3 PLAT	1.96e-04	191	67	4	f5ce33af56178333730be308253943c54a0724cf
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RAMP3 KIF26A PLAT TNKS1BP1	1.96e-04	191	67	4	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	droplet-Pancreas-PANCREAS-30m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL15A1 RAMP3 KIF26A PLAT	2.00e-04	192	67	4	f4cd65e6c5b17bcabf45fe5b687246c72e7975f7
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A4 PDPN COL15A1 MMP14	2.00e-04	192	67	4	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
Drug	Podophyllotoxin [518-28-5]; Up 200; 9.6uM; PC3; HT_HG-U133A	ABCA3 NRXN3 PDLIM3 TRIO CIZ1 PLAT	1.08e-05	187	61	6	5841_UP
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	ABCA3 NRXN3 BAZ2B EBLN2 RUSC2 FARP2	1.29e-05	193	61	6	7147_UP
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HT_HG-U133A	SOCS2 NRXN3 KCNG1 CACNA1I MMP14 PLXNB1	1.29e-05	193	61	6	6734_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A	ASXL1 MAN2B1 WDR6 KHNYN EBLN2 CIZ1	1.33e-05	194	61	6	1712_DN
Drug	Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ABL2 TRIO PCLO CIZ1 CACNA1I MMP14	1.41e-05	196	61	6	5397_UP
Drug	Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A	ABL2 TRIO FHOD1 PER1 CPNE7 FARP2	1.45e-05	197	61	6	5435_UP
Drug	Troleandomycin [2751-09-9]; Down 200; 5uM; PC3; HG-U133A	SOCS2 ASXL1 TRIO NOX5 KCNG1 CIZ1	1.50e-05	198	61	6	1885_DN
Drug	Glibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A	PDPN TRIO CIZ1 CACNA1I MUC2 RUSC2	1.50e-05	198	61	6	3163_UP
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; HL60; HT_HG-U133A	SOCS2 NOX5 CACNA1I CPNE7 RUSC2 SP140	1.50e-05	198	61	6	2138_UP
Drug	N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt; Down 200; 20uM; MCF7; HG-U133A	THBS4 ABL2 TRIO SENP3 MMP14 CPNE7	1.54e-05	199	61	6	591_DN
Drug	Khellin [82-02-0]; Up 200; 15.4uM; PC3; HG-U133A	ASXL1 ABL2 CIZ1 GMDS CACNA1I RUSC2	1.58e-05	200	61	6	1922_UP
Drug	2-aminopyridine	FANCB MAN2B1 PLAT F2	3.75e-05	70	61	4	CID000010439
Drug	taxa-4(5),11(12)-diene	NOX5 FARP2	7.02e-05	5	61	2	CID000443484
Drug	AC1Q5XME	PLAT F2	7.02e-05	5	61	2	CID000189740
Drug	Ro 44-9883	PLAT F2 MMP14	7.80e-05	31	61	3	CID000071453
Drug	aldosterone	SOCS2 RAMP3 NOX5 PER1 CACNA1I PLAT MMP14	9.02e-05	397	61	7	CID000005839
Drug	H743	PLAT F2	1.05e-04	6	61	2	CID005488509
Drug	Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	SOCS2 NRXN3 ABL2 MMP14 RUSC2	1.42e-04	186	61	5	6672_UP
Drug	trichostatin A; Down 200; 0.1uM; PC3; HG-U133A	ASXL1 BAZ2B KHNYN MMP14 MUC2	1.45e-04	187	61	5	448_DN
Drug	losigamone	PER1 CACNA1I	1.47e-04	7	61	2	CID000060572
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; HL60; HT_HG-U133A	SOCS2 ABCA3 PER1 MMP14 SP140	1.60e-04	191	61	5	2955_UP
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	FHOD1 PER1 PLAT MMP14 CPNE7	1.68e-04	193	61	5	2079_UP
Drug	Chlorzoxazone [95-25-0]; Down 200; 23.6uM; HL60; HG-U133A	ASXL1 WDR6 KHNYN EBLN2 CIZ1	1.72e-04	194	61	5	1416_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; HL60; HG-U133A	ASXL1 WDR6 KHNYN EBLN2 CIZ1	1.72e-04	194	61	5	2042_DN
Drug	5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA	SOCS2 ABCA3 KCNG1 KHNYN PLAT	1.77e-04	195	61	5	834_UP
Drug	Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A	PDPN PCLO CACNA1I MMP14 BBLN	1.77e-04	195	61	5	2426_UP
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A	ASXL1 WDR6 KHNYN SENP3 CIZ1	1.77e-04	195	61	5	1605_DN
Drug	Daunorubicin hydrochloride [23541-50-6]; Up 200; 7uM; MCF7; HT_HG-U133A	MAN2B1 PDLIM3 PLAT PLXNB1 CPNE7	1.77e-04	195	61	5	4983_UP
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	ABCA3 ABL2 PDLIM3 MMP14 FARP2	1.77e-04	195	61	5	7318_UP
Drug	cadmium	SOCS2 MAN2B1 NOX5 ACTBL2 CACNA1I PLAT FARP2	1.78e-04	443	61	7	CID000002514
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	KCNG1 PCLO PER1 MMP14 SP140	1.81e-04	196	61	5	3121_DN
Drug	Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A	ABCA3 KCNG1 MMP14 PLXNB1 CPNE7	1.81e-04	196	61	5	5069_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A	PDPN NRXN3 TRIO MMP14 CPNE7	1.85e-04	197	61	5	4433_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; PC3; HT_HG-U133A	ABCA3 NRXN3 PER1 MMP14 SP140	1.85e-04	197	61	5	6708_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	ABL2 BAZ2B KCNG1 CIZ1 PER1	1.85e-04	197	61	5	2228_DN
Drug	Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; HL60; HT_HG-U133A	SOCS2 PCLO MMP14 BBLN RUSC2	1.85e-04	197	61	5	2980_DN
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A	PDLIM3 CACNA1I CPNE7 RUSC2 FARP2	1.85e-04	197	61	5	6798_UP
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A	NRXN3 TRIO BAZ2B KCNG1 CPNE7	1.85e-04	197	61	5	3763_DN
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A	PCLO CACNA1I PLAT MMP14 CPNE7	1.85e-04	197	61	5	5394_UP
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	NRXN3 CIZ1 CACNA1I CPNE7 FARP2	1.85e-04	197	61	5	4024_DN
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; HL60; HG-U133A	ASXL1 WDR6 KHNYN EBLN2 CIZ1	1.85e-04	197	61	5	1402_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A	DPYD BAZ2B KHNYN CIZ1 GMDS	1.90e-04	198	61	5	1579_DN
Drug	Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PCLO CACNA1I MMP14 CPNE7 RUSC2	1.90e-04	198	61	5	6806_UP
Drug	Roxarsone [121-19-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A	PDPN COL15A1 RAMP3 TRIO CIZ1	1.90e-04	198	61	5	5470_UP
Drug	Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; HL60; HT_HG-U133A	SOCS2 ABL2 PLAT MUC2 CPNE7	1.90e-04	198	61	5	2983_DN
Drug	Tridihexethyl chloride; Down 200; 11.4uM; PC3; HT_HG-U133A	ABCA3 TRIO MUC2 PLXNB1 CPNE7	1.90e-04	198	61	5	5067_DN
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	PDPN PER1 CACNA1I PLAT SP140	1.90e-04	198	61	5	5797_UP
Drug	DL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA	ABCA3 TRIO BAZ2B KHNYN GMDS	1.90e-04	198	61	5	1121_UP
Drug	Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A	SOCS2 ABL2 KCNG1 PLAT FARP2	1.90e-04	198	61	5	4698_DN
Drug	Risperidone [106266-06-2]; Up 200; 9.8uM; HL60; HT_HG-U133A	SOCS2 PDPN FHOD1 BBLN CPNE7	1.90e-04	198	61	5	2947_UP
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; PC3; HT_HG-U133A	NRXN3 CIZ1 CACNA1I MMP14 CPNE7	1.94e-04	199	61	5	6686_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A	ABCA3 PER1 MMP14 CPNE7 RUSC2	1.94e-04	199	61	5	4523_DN
Drug	AC1NDMP4	PLAT F2	1.96e-04	8	61	2	CID004628293
Drug	Desaa-fibrin	PLAT F2	1.96e-04	8	61	2	CID000127263
Drug	diphosphoethanolamine	GTF2IRD1 DNMT1	1.96e-04	8	61	2	CID000193703
Drug	Etifenin [63245-28-3]; Up 200; 12.4uM; HL60; HT_HG-U133A	SOCS2 ABL2 KCNG1 CACNA1I PLAT	1.99e-04	200	61	5	2477_UP
Drug	Gdrgdsp	THBS4 ACTBL2 F2 MMP14	2.10e-04	109	61	4	CID000115346
Drug	dilazep	UPF2 PLAT F2	2.40e-04	45	61	3	CID000003074
Drug	F XV	PLAT F2	2.51e-04	9	61	2	CID004631609
Drug	cobalt phthalocyanine	NOX5 PER1	2.51e-04	9	61	2	CID000076829
Drug	docosahexaenoic acid hydroperoxide	FANCB NOX5	2.51e-04	9	61	2	CID006438991
Disease	hemolytic-uremic syndrome (is_marker_for)	PLAT F2	4.47e-05	5	63	2	DOID:12554 (is_marker_for)
Disease	disseminated intravascular coagulation (implicated_via_orthology)	PLAT F2	6.69e-05	6	63	2	DOID:11247 (implicated_via_orthology)
Disease	Venous Thromboembolism	PLAT F2	1.25e-04	8	63	2	C1861172
Disease	osteonecrosis (is_implicated_in)	PLAT F2	2.00e-04	10	63	2	DOID:10159 (is_implicated_in)
Disease	disseminated intravascular coagulation (is_marker_for)	PLAT F2	2.00e-04	10	63	2	DOID:11247 (is_marker_for)
Disease	factor VIII deficiency (is_implicated_in)	PLAT F2	2.44e-04	11	63	2	DOID:12134 (is_implicated_in)
Disease	Posterior Choroidal Artery Infarction	PLAT F2	2.44e-04	11	63	2	C0887799
Disease	Cerebral Infarction, Left Hemisphere	PLAT F2	2.44e-04	11	63	2	C0751010
Disease	Anterior Choroidal Artery Infarction	PLAT F2	2.44e-04	11	63	2	C0751012
Disease	Cerebral Infarction, Right Hemisphere	PLAT F2	2.44e-04	11	63	2	C0751011
Disease	Subcortical Infarction	PLAT F2	2.44e-04	11	63	2	C0751014
Disease	Cerebral Infarction	PLAT F2	2.44e-04	11	63	2	C0007785
Disease	Thromboembolism	PLAT F2	2.92e-04	12	63	2	C0040038
Disease	bacterial pneumonia (biomarker_via_orthology)	PDPN F2	4.02e-04	14	63	2	DOID:874 (biomarker_via_orthology)
Disease	body surface area	SOCS2 NRXN3 FBN2 PER1 GMDS TSEN15 DNMT1	4.34e-04	643	63	7	EFO_0022196
Disease	brain edema (biomarker_via_orthology)	PLAT F2	4.63e-04	15	63	2	DOID:4724 (biomarker_via_orthology)
Disease	severe aplastic anemia	DPYD FBN2	4.63e-04	15	63	2	EFO_0006927
Disease	Schizoaffective disorder-bipolar type	NRXN3 PCLO	5.28e-04	16	63	2	EFO_0009965
Disease	Pontoneocerebellar hypoplasia	PCLO TSEN15	5.28e-04	16	63	2	cv:C1261175
Disease	smoking cessation	ASXL1 DPYD NRXN3 KIF26A CPNE7	6.55e-04	325	63	5	EFO_0004319
Disease	Hemorrhage	PLAT F2	8.32e-04	20	63	2	C0019080
Disease	Deep Vein Thrombosis	PLAT F2	9.18e-04	21	63	2	C0149871
Disease	Venous Thrombosis	PLAT F2	9.18e-04	21	63	2	C0042487
Disease	myocardial infarction (is_implicated_in)	PLAT F2 MMP14	1.26e-03	99	63	3	DOID:5844 (is_implicated_in)
Disease	Myeloid Leukemia, Chronic	ASXL1 PER1	1.76e-03	29	63	2	C0023473
Disease	Carcinoma, Granular Cell	MMP14 MUC2 DNMT1	1.98e-03	116	63	3	C0205644
Disease	Adenocarcinoma, Tubular	MMP14 MUC2 DNMT1	1.98e-03	116	63	3	C0205645
Disease	Adenocarcinoma, Oxyphilic	MMP14 MUC2 DNMT1	1.98e-03	116	63	3	C0205642
Disease	Carcinoma, Cribriform	MMP14 MUC2 DNMT1	1.98e-03	116	63	3	C0205643
Disease	Adenocarcinoma, Basal Cell	MMP14 MUC2 DNMT1	1.98e-03	116	63	3	C0205641
Disease	Adenocarcinoma	MMP14 MUC2 DNMT1	1.98e-03	116	63	3	C0001418

Protein segments in the cluster

Peptide	Gene	Start	Entry
CEGDLVSPMGGGLSA	UMODL1	551	Q5DID0
SGGRAGPGELGDMCE	CEBPE	21	Q15744
EGGMDPESLLEGDDG	DNMT1	846	P26358
GARLGMAGVPEDGEQ	ABL2	896	P42684
GMCKAGFGGDDAPRA	ACTBL2	16	Q562R1
QCGGIFVEGMESGEG	BAZ2B	1391	Q9UIF8
GGGQALMSPGSCLED	COL4A4	1611	P53420
DSNLCGAMDPSDGIG	ABCA3	871	Q99758
GERGMGLACGQDPEL	DPYD	676	Q12882
MCPEEGGAAGLGELR	CECR2	1	Q9BXF3
AFDDELGLGGSCPPM	ASXL1	861	Q8IXJ9
MGCPSGGRPDEGTEE	MMP14	506	P50281
GCPRAGGCNETGMLE	RAMP3	21	O60896
GPEGCRGTMSAEEDA	NOX5	11	Q96PH1
MCQGGDFTRPNGTGD	PPIAL4C	61	A0A0B4J2A2
RPGEGDDGSMEPGTC	NCKAP5L	16	Q9HCH0
ARCPSARGSGDGEMG	GMDS	6	O60547
MDPKAGGGGEEDDCV	FAM124A	1	Q86V42
REEMDEGGLLCGEGP	NHSL1	1561	Q5SYE7
SELDGLGLEPMEEGG	PER1	1221	O15534
MGNEASLEGEGLPEG	PCLO	1	Q9Y6V0
GPGDNECVMELEGLE	PLXNB1	946	O43157
VCPDGLMDDGRGGCV	MUC2	801	Q02817
GDDAMDRSGLPDLQG	EBLN2	61	Q6P2I7
PAPGDGSKERMCGEE	FAM169B	146	Q8N8A8
MDAEGPCGERPCENG	NRXN3	196	Q9Y4C0
ERLECMDGNEGPSGG	KIF26A	846	Q9ULI4
SEGPAEGEGRLGRCM	KCNG1	196	Q9UIX4
MCQGGDFTRPNGTGD	PPIAL4F	61	P0DN26
MCQGGDFTRPNGTGD	PPIAL4E	61	A0A075B759
FGDPCAVQLMDSGGG	FANCB	281	Q8NB91
MCQGGDFTRPNGTGD	PPIAL4D	61	F5H284
PDLGMINDGTSCGEG	ADAM30	601	Q9UKF2
RLAQPGMGGAEAEDE	DACT3	46	Q96B18
ECGDGPDGQEMGLPN	GAGE10	86	A6NGK3
DSMDPSDEEGRGGAG	CACNA1I	2101	Q9P0X4
EDDFLGGMECTLGQP	CPNE7	106	Q9UBL6
MDGEEKTYGGCEGPD	ELOC	1	Q15369
GDLGMPVEAGAEGEE	BBLN	6	Q9BUW7
DGRGVSEPLMENGSG	MAN2B1	821	O00754
GRESLDTGSMGPGDC	KHNYN	231	O15037
GEEEEQPRMCPRCGG	DCAF8L1	111	A6NGE4
GMARRPDGEGCVDEN	FBN2	2326	P35556
MAGGEDRGDGEPVSV	FHOD1	1	Q9Y613
MSEDCGPGTSGELGG	GTF2IRD1	476	Q9UHL9
PVLSDAGGAGMDCEE	FARP2	511	O94887
PGCTMGLGFEDTEGS	COL15A1	731	P39059
LGGGEGEAESADTMP	UPF2	1156	Q9HAU5
EAETMELDECGGPGG	RUSC2	196	Q8N2Y8
GLEGGVAMPGAEDDV	PDPN	36	Q86YL7
GGRDACQGDSGGSLM	OVCH2	231	Q7RTZ1
GDDVQTGGPGAEEMR	ERCC5	406	P28715
MTLRCLEPSGNGGEG	SOCS2	1	O14508
LQGMVDDGSDDRPAG	PDLIM3	256	Q53GG5
GSPGGLDMTEEELGA	STARD9	4151	Q9P2P6
CGLEMPPDAVEAGGG	CIZ1	486	Q9ULV3
QGSDLGMAEEAERPG	SENP3	286	Q9H4L4
GRGDACDDDMDGDGI	THBS4	561	P35443
GDSGGPLVCLNDGRM	PLAT	511	P00750
MAEGGGCRERPDAET	USP4	1	Q13107
PGSADLEDGEMGKRG	TNKS1BP1	1071	Q9C0C2
GPEGFGLCAMANGEG	WDR6	401	Q9NNW5
NVCLEIMEPGGDGGE	ZBTB7C	121	A1YPR0
GDACEGDSGGPFVMK	F2	561	P00734
LPGEGEEGSDDCSEM	SP140	381	Q13342
PEGRGESRCQGMHEG	ZNF831	226	Q5JPB2
MEERGDSEPTPGCSG	TSEN15	1	Q8WW01
GMQSCGEEEGEEGAD	TRIO	1851	O75962